C
Celldex Therapeutics, Inc. (CLDX)
NCM – Real Time Price. Currency in USD
32.00
-0.28 (-0.87%)
At close: May 12, 2026, 4:00 PM EDT
32.00
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
32.00
-0.28 (-0.87%)
At close: May 12, 2026, 4:00 PM EDT
32.00
0.00 (0.00%)
After-hours: May 12, 2026, 4:10 PM EDT
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company’s drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. It develops clinical programs, including Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. Celldex Therapeutics, Inc. is headquartered in Hampton, New Jersey.
| Name | Position |
|---|---|
| Dr. Diane C. Young M.D. | Senior VP & Chief Medical Officer |
| Dr. Margo Heath-Chiozzi M.D. | Senior Vice President of Regulatory Affairs |
| Dr. Ronald A. Pepin Ph.D. | Chief Business Officer & Senior VP |
| Dr. Tibor Keler Ph.D. | Founder, Chief Scientific Officer & Executive VP |
| Mr. Anthony S. Marucci M.B.A. | Founder, President, CEO & Director |
| Mr. Freddy A. Jimenez Esq. | Senior VP & General Counsel |
| Mr. Sam Martin CPA | Senior VP, CFO, Secretary & Treasurer |
| Ms. Elizabeth Crowley | Chief Product Development Officer & Senior VP |
| Ms. Sarah Cavanaugh | Senior Vice President of Corporate Affairs & Administration |
| Prof. Joseph P. Schlessinger Ph.D. | Co-Founder & Member of Scientific Advisory Board |
| Date | Type | Document |
|---|---|---|
| 2026-05-07 | 8-K | f8k_050726.htm |
| 2026-05-07 | 10-Q | cldx-20260331x10q.htm |
| 2026-04-29 | DEF 14A | tm261321-3_def14a.htm |
| 2026-04-29 | ARS | tm261066d3_ars.pdf |
| 2026-04-02 | 8-K | tm267111d2_8k.htm |
| 2026-02-25 | 8-K | f8k_022526.htm |
| 2026-02-25 | 10-K | cldx-20251231x10k.htm |
| 2025-11-10 | 8-K | f8k_111025.htm |
| 2025-08-19 | 8-K | tm2523903d1_8k.htm |
| 2025-08-07 | 8-K | f8k_080625.htm |